Insight Molecular Diagnostics Inc. Loans Payable, Noncurrent
Insight Molecular Diagnostics Inc. (IMDX) had Loans Payable, Noncurrent of $178.00 thousand as of 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermLoansPayable · last filed 2022-03-11
- 2021-09-30: Loans Payable, Noncurrent $178.00K.
- 2021-06-30: Loans Payable, Noncurrent $541.00K.
- 2021-03-31: Loans Payable, Noncurrent $951.00K.
- 2020-12-31: Loans Payable, Noncurrent $1.51M.
| Period end | Loans Payable, Noncurrent |
|---|---|
| 2021-09-30 | $178.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $541.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $951.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.51M 10-K · filed 2022-03-11 |
| 2020-09-30 | $2.06M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $2.62M 10-Q · filed 2020-07-29 |
| 2020-03-31 | $1.56M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $1.91M 10-K · filed 2021-03-19 |
| 2019-03-31 | $159.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $347.00K 10-K · filed 2020-03-26 |
| 2018-09-30 | $531.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $713.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $893.00K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $1.07M 10-K · filed 2019-04-01 |
| 2017-09-30 | $1.24M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $1.42M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $1.59M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $0.00 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |